News

MAXONA PHARMACEUTICALS SUBMITS INVESTIGATIONAL NEW DRUG APPLICATION TO THE U.S. FOOD AND DRUG ADMINISTRATION FOR MAX-001
MAXONA Pharmaceuticals today announced that the company has submitted an Investigational New Drug (IND) Application to the ...
FDA clears Starlight Therapeutics’ IND for Phase Ib/IIa glioblastoma trial
The trial aims to assess the tolerability, preliminary efficacy, and safety of the combination therapy in individuals with ...
Targeted Oncology22h
FDA Clears IND for GLIX1 in Glioblastoma, Phase 1 Study to Proceed
Hemispherian's GLIX1 gains FDA approval for glioblastoma trials, promising a novel therapy targeting DNA repair in tumor ...
InvestorsHub on MSN3d
CASI Pharmaceuticals Stock Surges 12.4% Following FDA Clearance for Transplant Drug
CASI Pharmaceuticals Inc (NASDAQ:CASI) shares jumped 12.4% after the clinical-stage biopharmaceutical company announced the U ...
CURE3d
FDA Approves Application for ABT-301 in Metastatic Colorectal Cancer
The FDA approved an investigational new drug application for ABT-301, clearing the way for a new clinical trial in metastatic ...
Morningstar1mon
U.S. Food & Drug Administration (FDA) Approves Investigational New Drug ...
News PR Newswire U.S. Food & Drug Administration (FDA) Approves Investigational New Drug (IND) Application for Myrio's Lead Product (PHOX2B PC-CAR T) for the Treatment of Neuroblastoma ...
Fierce Biotech8d
FDA misses IND deadline for Coya's ALS asset, cites lack of resources
The FDA has missed the date for Coya Therapeutics’ investigational new drug (IND) application, citing a lack of resources and ...
TipRanks on MSN4d
Alphamab Oncology’s JSKN022 IND Application Accepted by CDE
Alphamab Oncology ( ($HK:9966) ) has shared an update. Alphamab Oncology announced that its Investigational New Drug application for JSKN022, a ...
Morningstar2mon
YolTech Therapeutics Announces FDA Clearance of Investigational New ...
YolTech Therapeutics Announces FDA Clearance of Investigational New Drug (IND) Application for YOLT-101, an In Vivo Base Editing Therapy to Treat Heterozygous Familial Hypercholesterolemia (HeFH) ...